Cargando…

Graft-Versus-Host Disease: A Surge of Developments

Stanley Riddell and Frederick Appelbaum review progress in preventing graft-versus-host disease following allogeneic hematopoietic cell transplantation for malignancies or other life-threatening blood diseases.

Detalles Bibliográficos
Autores principales:	Riddell, Stanley R, Appelbaum, Frederick R
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research in Translation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913094/ https://www.ncbi.nlm.nih.gov/pubmed/17622190 http://dx.doi.org/10.1371/journal.pmed.0040198

Ejemplares similares

Therapy with mycophenolate mofetil for refractory acute and chronic graft-versus-host disease
por: Furlong, Terry, et al.
Publicado: (2009)

Transplantation of Donor‐Origin Mouse Embryonic Stem Cell‐Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft‐versus‐Host Disease in Mice
por: Hu, Rong, et al.
Publicado: (2016)

2050 Identifying the role and immunobiological mechanisms of Fli-1 mediated pathogenicity in graft Versus host disease
por: Schutt, Steven, et al.
Publicado: (2018)

The development of graft-versus-host disease prophylaxis
por: Cutler, Corey
Publicado: (2023)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)

Empyema as a Result of Pleuro-Pneumonia
por: Peterson, Frederick
Publicado: (1880)

Immunologic goalposts for TB vaccine development
por: Um, Peter K., et al.
Publicado: (2021)

Graft-versus-host disease after liver transplantation
por: Chaib, Eleazar, et al.
Publicado: (2011)

Transfusion-associated graft-versus-host disease.
por: Rappeport, J. M.
Publicado: (1990)

Clinical versus histological grading in the assessment of cutaneous graft versus host disease
por: Hogenes, M. C. H., et al.
Publicado: (2019)

Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease
por: Sheshadri, Ajay, et al.
Publicado: (2022)

Iodoform as a Dressing, Especially in Tubercular Ulcerations of Bones and Joints
por: Mikulicz,, et al.
Publicado: (1881)

Perleche, a New Parasitic Disease of Children
por: Campbell, F. R.
Publicado: (1886)

Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice
por: Rezende, Barbara Maximino, et al.
Publicado: (2019)

Minimal change disease in graft versus host disease: a podocyte response to the graft?
por: Huskey, Janna, et al.
Publicado: (2013)

Isomorphic Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease: Report and Review of Chronic Graft-Versus-Host Disease in a Cutaneous Immunocompromised District
por: Cohen, Philip R.
Publicado: (2013)

Progress in chronic graft-versus-host disease
por: Martin, Paul J
Publicado: (2011)

Oral features of graft-versus-host disease
por: Regina Torres, Sandra
Publicado: (2014)

Transfusion Associated Graft Versus Host Disease
por: Naveen, Kikkeri Narayanshetty, et al.
Publicado: (2015)

Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)

Ruxolitinib for Therapy of Graft-versus-Host Disease
por: Neumann, Thomas, et al.
Publicado: (2019)

T-Cell Metabolism in Graft Versus Host Disease
por: Karl, Franziska, et al.
Publicado: (2021)

Update on ocular graft-versus-host disease
por: Nair, Sridevi, et al.
Publicado: (2021)

T cell metabolism in graft-versus-host disease
por: Zou, Yujing, et al.
Publicado: (2020)

Oral Chronic Graft-Versus-Host Disease
por: Dean, David, et al.
Publicado: (2022)

Novel Treatment for Graft-versus-Host Disease
por: Inamoto, Yoshihiro, et al.
Publicado: (2021)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
por: Kim, Sena, et al.
Publicado: (2020)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
por: Dekker, Linde, et al.
Publicado: (2022)

Follicular Graft-versus-host Disease: A Rare Manifestation in a Patient with the Overlap Subtype of Chronic Graft-versus-host Disease
por: Ho, Yi-Hsin, et al.
Publicado: (2019)

The Role of Regulatory T Cells in the Biology of Graft Versus Host Disease
por: Beres, Amy J., et al.
Publicado: (2013)

Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation
por: Saberian, Chantal, et al.
Publicado: (2021)

Experiments on the Proliferation and Development of Leucocytes
por: Reinke,
Publicado: (1890)

Granulysin-Bearing Cells in the Skin Lesions of Acute Graft-versus-Host Disease: Possible Mechanisms for Hypohidrosis in Graft-versus-Host Disease
por: Furudate, Sadanori, et al.
Publicado: (2013)

Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses
por: Bolivar-Wagers, Sara, et al.
Publicado: (2022)

Overcoming Barriers to Development of Novel Therapies for Cardiovascular Disease: Insights From the Oncology Drug Development Experience
por: Khakoo, Aarif Y., et al.
Publicado: (2019)

Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation
por: Castilla-Llorente, Cristina, et al.
Publicado: (2014)

Attenuated reovirus displays oncolysis with reduced host toxicity
por: Kim, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_v42l17iskt11b39kfqt9i1ipfo